On the other hand, KLF4’s ability to regulate the stemness of cancer cells has been shown as an important factor in stimulating EMT in pancreatic, ovarian, endometrial, nasopharyngeal, prostate, and non-small cell lung cancers[34–40]. This evidence concerns the gene KLF4 and cancer.